These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16039177)

  • 1. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection.
    Perrot E; Guibert B; Mulsant P; Blandin S; Arnaud I; Roy P; Geriniere L; Souquet PJ
    Ann Thorac Surg; 2005 Aug; 80(2):423-7. PubMed ID: 16039177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleeve lobectomy compared with pneumonectomy after induction therapy for non-small-cell lung cancer.
    Maurizi G; D'Andrilli A; Anile M; Ciccone AM; Ibrahim M; Venuta F; Rendina EA
    J Thorac Oncol; 2013 May; 8(5):637-43. PubMed ID: 23584296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is pneumonectomy after induction chemotherapy for non-small cell lung cancer a reasonable procedure? A multicenter retrospective study of 228 cases.
    Thibout Y; Guibert B; Bossard N; Tronc F; Tiffet O; de la Roche E; Mulsant P; Gamondes JP; Baulieux J; Remontet L; Geriniere L; Souquet PJ
    J Thorac Oncol; 2009 Dec; 4(12):1496-503. PubMed ID: 19745768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
    Torre W; Sierra A
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer.
    Chen S; Cheng YL; Li ST; Ni YJ; Gu B
    Asian Pac J Trop Med; 2012 Oct; 5(10):823-7. PubMed ID: 23043924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.
    Martin J; Ginsberg RJ; Abolhoda A; Bains MS; Downey RJ; Korst RJ; Weigel TL; Kris MG; Venkatraman ES; Rusch VW
    Ann Thorac Surg; 2001 Oct; 72(4):1149-54. PubMed ID: 11603428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy for lung cancer does not increase surgical morbidity.
    Siegenthaler MP; Pisters KM; Merriman KW; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Smythe WR; Putnam JB
    Ann Thorac Surg; 2001 Apr; 71(4):1105-11; discussion 1111-2. PubMed ID: 11308144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party.
    Berghmans T; Lafitte JJ; Giner V; Berchier MC; Scherpereel A; Lewin D; Paesmans M; Meert AP; Bosschaerts T; Leclercq N; Sculier JP;
    Lung Cancer; 2012 Sep; 77(3):605-10. PubMed ID: 22704426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine-cisplatin chemotherapy before lung resection: a case-matched analysis of early outcome.
    Brunelli A; Xiume' F; Al Refai M; Salati M; Marasco R; Sabbatini A
    Ann Thorac Surg; 2006 Jun; 81(6):1963-8. PubMed ID: 16731114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
    Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD
    Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
    Boudaya MS; Smadhi H; Marghli A; Charmiti F; Ouerghi S; Mohamed J; Brahem E; Smati B; Mestiri T; Kilani T
    Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):432-6. PubMed ID: 24570525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
    Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
    Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.
    Dingemans AM; Bootsma G; van Baardwijk A; Reymen B; Wanders R; Brans B; Das M; Hochstenbag M; van Belle A; Houben R; Lambin P; de Ruysscher D
    J Thorac Oncol; 2014 May; 9(5):710-6. PubMed ID: 24722157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant vinorelbine and cisplatin after complete resection of stage II and III non-small cell lung cancer: long-term follow-up of our study of Japanese patients.
    Sonobe M; Hamaji M; Motoyama H; Menju T; Aoyama A; Chen-Yoshikawa TF; Sato T; Date H
    Surg Today; 2018 Jul; 48(7):687-694. PubMed ID: 29502152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer.
    Luo J; Leaw SJ; Xu Y; Zheng D
    Med Oncol; 2011 Dec; 28(4):1418-24. PubMed ID: 20661668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
    Rivera MP; Detterbeck FC; Socinski MA; Moore DT; Edelman MJ; Jahan TM; Ansari RH; Luketich JD; Peng G; Monberg M; Obasaju CK; Gralla RJ
    Chest; 2009 Jun; 135(6):1588-1595. PubMed ID: 19188545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.